Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859635 · ClinicalTrials.gov registry record · Phase 3
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
A Phase 3 study of Pain, Postoperative and Acute Pain, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03859635: Completed Phase 3 study of Pain, Postoperative and Acute Pain, sponsored by Indiana University.
NCT03859635 is a Phase 3 study of Pain, Postoperative and Acute Pain that has completed, run by Indiana University. The registered enrollment target is 120 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03859635, a Phase 3 study of Pain, Postoperative and Acute Pain, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is comparing the difference between erector spinae block and surgeon infiltration after VATS (Video Assisted Thoracoscopic Surgery). The outcomes measured are pain scores, opioid usage, opioid side effects, and patient satisfaction.We are also also studying the effectiveness of liposomal bupivacaine (EXPAREL) in a block by randomizing patients to both EXPAREL erector spinae block and simple bupivacaine erector spinae block.
Primary Outcome
The VAS score will be taken at rest using Visual Analog Scale (VAS). Using a scale of 0-10 for documentation with 10 being the worst pain and 0 being no pain
Conditions Studied
Interventions
- DRUG Liposomal Bupivacaine
- DRUG Bupivacaine, 0.25%
- DRUG Bupivacaine, 0.5%
Study Locations (1)
Indiana
- Indiana University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2022-11-07 |
| Phase | Phase 3 |
What the finished NCT03859635 record still lists
NCT03859635 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (56% lower).
The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Liposomal Bupivacaine is the first listed.
NCT03859635 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03859635 about?
NCT03859635 is a clinical study titled "Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures". The study is comparing the difference between erector spinae block and surgeon infiltration after VATS (Video Assisted Thoracoscopic Surgery). The outcomes measured are pain scores, opioid usage, opioid side effects, and patient satisfaction.We are also also studying the effectiveness of liposomal b...
What is the current status of trial NCT03859635?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2019-02-07. Estimated completion is 2022-11-07.
What conditions does trial NCT03859635 study?
This clinical trial studies the following conditions: Pain, Postoperative, Acute Pain, Thoracic.
What interventions are being tested in trial NCT03859635?
The interventions under investigation include: Liposomal Bupivacaine (DRUG), Bupivacaine, 0.25% (DRUG), Bupivacaine, 0.5% (DRUG).
Who is sponsoring clinical trial NCT03859635?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03859635 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03859635's enrollment target sits among peer trials
120 35th of 113 higher than 75 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Evaluate Efficacy and Safety of Extended Release (ER) Naproxen Sodium
COMPLETED · Phase 3
-
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
COMPLETED · Phase 3
-
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI